Paul Korner Seminar Series

The Paul Korner Seminars are presented weekly, giving young scientists within the Victor Chang Institute the opportunity to present some of the groundbreaking work they are carrying out within individual research programs.

This Seminar Series established in 1998 is named in honour of Paul Korner in recognition of his outstanding contribution to cardiovascular research.

Sadly, Professor Korner passed away on October 4, 2012.

Emeritus Professor Paul Korner graduated from the University of Sydney in Science and Medicine, and obtained his clinical training at Royal Prince Alfred Hospital. This was followed by a period of research training at the Kanematsu Memorial Institute of Pathology at Sydney Hospital, and then overseas at the (now) Royal Postgraduate Medical School, Hammersmith Hospital in London (Department of Medicine), and the Harvard Medical School (Department of Physiology) in Boston.

Paul Korner returned to Australia in 1956 to the Department of Physiology, University of Sydney.  In 1960 Paul Korner became Foundation Professor of Physiology at the University of New South Wales. With an initial intake of 48 students, there was an opportunity for applying Harvard style teaching methods and still have time left for research. In 1968 Paul Korner left to become Scandrett Professor of Cardiology at the University of Sydney where he stayed until the end in 1974.

In 1975 he became Director at the Baker Medical Research Institute, which had facilities for basic research and facilities for clinical research in the adjoining Alfred Hospital. The Baker Institute became the first in Australia entirely dedicated to cardiovascular research, with the main focus on hypertension and atherosclerosis. Paul Korner retired in 1990 and returned to Sydney, where he is currently a visiting professor at the University of New South Wales.

His personal research was on how the autonomic nervous system operated in the intact organism, and on the mechanisms that cause hypertension. He was the author and co-author of some 330 papers, chapters etc; as well as the author of a book on ‘Hypertension, Brain and Circulatory Control’ that grapples with the causes of hypertension.

Paul Korner was an Officer of the Order of Australia, and a Fellow of the Australian Academy of Science. However, his greatest pleasure was perhaps seeing the number of his former colleagues and associates occupy chairs and research positions in Australian Universities.

Each year a prize is given to the best presenter and runner up of the series.

Vale Professor Korner, AO, FAAS, 18/11/25 – 04/10/12.

Past Winners of The Paul Korner Seminar Series:

2011

Dr Duncan Sparrow (Winner) Talk Title: Congenital scoliosis: getting to the heart of the problem

Dr Charles Cranfield (Runner Up) Talk Title: Clustering of the Mechanosensitive Ion Channels MscS and MscL: A FRET-FLIM study

Dr Stefan Mann (Staff Choice Winner) Talk Title: The genetic wheel of fortune – epistatic effects of potassium channel variation on Atrial Fibrillation

2010

Alistair Stewart (Winner) Talk Title: Thermus thermophilus H+-ATPase/synthase. Dr Chu Kong Liew + Liz Yeo (Joint runners up) Talk Titles: “Towards the structure of a serpentine receptor: A game of snakes and ladders” and “Evaluation of mechanisms of contractile dysfunction in Lamin A/C-deficient mice”

Dr David Szekely (Staff Choice winner) Talk Title: The Virtual Heart: Efficient and Interactive Simulations of Cardiac Electrical Function

2009

Dr Lawrence Lee (Winner) Talk Title: The Victor Chang’s first protein crystal structure – The molecular basis for rotation and switching of the bacterial flagellar rotary motor

Dr Chris Blair (Runner Up) Talk Title: Mesenchymal stem cell transplantation for functional recovery following acute myocardial infarction. Sharon Chih (Staff Choice winner) Talk title: Granulocyte-colony stimulating factor to stimulate neovascularisation in chronic angina. Liz Yeo (Staff Choice Runner up) Talk title: Evaluation of mechanisms of contractile dysfunction in mouse model of dilated cardiomyopathy, Lamin A/C-deficient mice

2008

Dr Adam Hill (Winner) Talk Title: Risk stratification in LQTS2: Laboratory insights into a clinical problem
Dr Traude Beilharz (Runner Up) Talk Title: Finding the targets of miRNA mediated repression
Leah Cannon & Lawrence Lee (Joint Staff Choice Winners) Talk Titles: Characterisation of a regulatable mouse model of left ventricular hypertrophy; Unsolved mysteries of the rotary ATPase enzymes “Marvelous rotary engine(s) of the cell”

2007

Dr Gavin Chapman & Dr Robert Bryson-Richardson (Joint Winners) Talk Titles: The role of DII3 during Notch signal transduction and somitogenesis; Slow muscle formation and FishNet: Zebrafish development in three dimensions
Christiana Leimena (Staff Choice) Talk Title: Role of BKCa channel in normal cardiomyocyte function and in heart disease

2006

Ms Milena Furtado (Winner) Talk Title: MAD about SMADs: The role of BMP signalling in left-right patterning
Dr Tom Hall (Runner Up) Talk Title: From phenotype to gene: What’s wrong with my fish

2005

Dr Owen Prall (Winner) Talk Title: How the heart rules the head: Nkx2-5 regulates multiple progenitor cell types in vivo
Dr Jason Kovacic (Runner Up) Talk Title: A stem cell based approach to chronic refractory myocardial ischaemia

2004

Ms Vesna Nikolova (Winner) Talk Title: Getting to the core of heart disease!
Dr Georgina Hollway (Runner Up) Talk Title: Hedgehog needs you

2003

Dr David Humphreys (Winner) Talk Title: New tools for analysing microRNAs
Miss Kylie Lopes Floro (Runner Up) Talk Title: Exciting developments: Cited2 and the heart

2002

Dr Duncan Sparrow (Winner) Talk Title: “Cited 1: Coming soon to a branch near you?”
Miss Bryrony Mearns (Runner Up) Talk Title: Inactivation of Gh results in delayed wound healing and altered fibroblast cytoskeletal dynamics

2001

Dr Christine Biben (Winner) Talk Title: Laterality and heart development
Ms Nisha Nanda (Runner Up) Talk Title: Targetted inactivation of Gh/Tissue transglutaminase

2000

Dr Sirri Iismaa (Winner) Talk Title: Transmembrane signalling mediated by the high-molecular-weight G-protein, Gh
Dr Gillian Begg (Runner Up) Talk Title: Does overexpression of ErbB-2 in fibroblasts cause cell growth arrest?

1999

Mr Cheng Chun Wang (Winner)
Dr Siri Iismaa (Runner Up)

1998

Dr Merridee Wouters (Winner) Talk Title: Carboxypeptidase A and Thermolysin share a common fold
Dr Christine Biben (Runner Up) Talk Title: Nkx2-5 and heart development

LATEST EVENTS

All Events

Polo in the City

18.06.2014

Polo in the City
More

The Victor Chang 20th Anniversary Ball

18.06.2014

Victor Chang 20th Anniversary Ball
More

Heme Oxygenase 2014

24.09.2013

Save the date for 8th international Heme Oxygenase conference
More

ASK THE INSTITUTE

Do you have a question but cannot find the answer?

ask the institute

Privacy Policy

1. Our privacy commitment

The Victor Chang Cardiac Research Institute respects your privacy.

We collect, store and use your personal information to help us fight heart disease. This Privacy Policy explains how we handle the personal information we collect relating to our fundraising activities – this includes marketing, events, our website, and health promotion services such as the Health Check Booth.

2. What types of personal information we collect

Personal information means information that identifies you or that could reasonably be used to identify you. The types of personal information we collect may include your name, gender, contact information, email address, credit/debit card information and if you consent to take part in our activities and events, health promotion services or to receive marketing materials from us.

3. Health information and other sensitive information

We do not collect health information or other types of sensitive information as part of our general fundraising activities or through our general web-site.

4. Using unsolicited information

Unsolicited information is information that is given to us that we haven’t asked for, from you or anyone else. If we receive this type of information, we will check whether this information is reasonably necessary for what we do. If it is, we’ll handle this information in the same way we do all personal information under privacy laws. If we don’t need it we’ll destroy or de-identify it.

5. How we collect your personal information

Where possible, we will collect your personal information directly from you. This may be in person (e.g. when you attend an event), on the telephone, or on-line.

We only collect information by lawful and fair means.

We may also obtain personal information from third parties or publicly available sources. In this case, we will take reasonable steps to contact you and ensure that you are aware of the circumstances surrounding the collection and purposes for which we collected your personal information.

6. Why we collect your personal information

We may collect your personal information for a number of purposes, including:

  • Marketing: to communicate with you about donations, our activities and fundraising events.
  • Health promotion: to provide you with services and information related to cardiovascular disease and its risk factors and research-related events and seminars.
  • Other activities: communicating with you to verify your identity, to improve and evaluate our programs and services, and to comply with relevant laws.

7. What happens if you don’t provide your information?

If you do not provide some or all of the personal information requested, we may not be able to offer you services, process your donations, or provide you with information about our events and activities.

8. Using a pseudonym or engaging with us anonymously

Anonymous donations may be made to the Victor Chang Cardiac Research Institute at any time by contacting us directly. Please note that we are unable to provide anonymous donors with receipts.

If you want to make a general enquiry or browse our web-site you can do so anonymously.

9. Website usage information and cookies

We do not use ‘cookies’ or any other methods to record information that is personally identifiable such as a visitor’s contact details, IP address, or domain name. We do use ‘cookies’ to anonymously track visits to our web pages and the documents that are downloaded in order to compile statistical information. This provides us with information about which pages are popular. If you prefer for ‘cookies’ not to be used, you can set your browser to disable them.

10. When we disclose your personal information

We may need to disclose your personal information to our agents in order to carry out our fundraising activities. This may include agencies who perform services on our behalf, such as mailing houses, printers, information technology services providers, archiving services, database services and telemarketing agencies. These services will always be provided under strict confidentiality agreements.

In rare cases, we may be required by law to disclose your information to a government or law enforcement agency (for example to investigate an allegation of credit card fraud).

11. Security of our information

We take all reasonable steps to protect the personal information we hold from misuse, interference and loss, and from unauthorised access. Electronic information is stored on secure servers that are protected in controlled facilities.

We do not use data hosting facilities or third party service providers that store information overseas.

Hard copy information is generally stored in our offices, which are secured to prevent entry by unauthorised people. Any personal information not actively being used is archived, usually for 7 years, with a third party provider of secure archiving services. Where personal information is stored with a third party, we have strict agreements in place that require those third parties to maintain the security of the information.

12. Security of direct debit and credit card information

We use a third-party financial institution to process our credit card transactions. It receives the credit card number and other personal information of our donors only to verify credit card numbers and to process credit card transactions in a secure environment. Where your financial information is stored on our servers, access to this information is restricted to our authorised staff only.

13. Accessing or changing your personal information

We take reasonable steps to make sure that the information we collect and use is accurate, up-to-date and complete. You may contact our Fund Development Officer at any time if you wish to:

  • change or correct your personal information (for example address or telephone number)
  • cancel some or all of the communications that we provide (we include opt-out mechanisms on the majority of our communications)
  • request access to the information that we hold about you
  • request further information about our privacy policy.

14. Questions and complaints

If you have any questions, concerns or complaints about the way in which we have handled your personal information, please contact our Fund Development Officer.

Once we receive a complaint, we will respond to you as soon as possible and will let you know if we need any further information from you. We will notify you of our decision within 30 days, however, if we are unable to do so, we will let you know the reason for the delay and the expected timeframe for resolving the complaint.

You may also lodge a complaint with the Office of Australian Information Commissioner, for more information visit www.oaic.gov.au.

15. How to contact the Fund Development Officer

Email:

victorchang@victorchang.edu.au

Post:

Victor Chang Cardiac Research Institute
PO Box 699
Darlinghurst NSW 2010

Telephone 1300 842 867

For a copy of our full privacy policy, please click here.

Updated: March 2014

OK